Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mitsuhiko, Hanawa"'
Autor:
Atsuko Kitahashi, Ikko Watanabe, Masahiko Ohtaka, Yuichi Hirose, Kazuhiko Takaso, Mika Miura, Mitsuhiko Hanawa, Naoki Imamura, Nobuyuki Enomoto, Yoshioki Yoda, Naoki Shimura, Mitsuharu Fukasawa, Ichiro Takayama
Publikováno v:
Open Journal of Gastroenterology. :27-38
Aim: To investigate the efficacy and tolerability of second-line metronidazole triple therapy with vonoprazan (VPZ) for Helicobacter pylori (H. pylori). Methods: We retrospectively reviewed medical records of patients who experienced clarithromycin t
Publikováno v:
Open Journal of Gastroenterology. :243-259
Aim: To investigate the factors related to the effect of eradication therapy with vonoprazan for Helicobacter pylori (H. pylori). Methods: We retrospectively reviewed medical records of H. pylori-positive patients who received first-line (40 mg vonop
Autor:
Mika, Miura, Masahiko, Ohtaka, Mitsuhiko, Hanawa, Atsuko, Kitahashi, Yuichi, Hirose, Kazuhiko, Takaso, Yoshioki, Yoda, Ichiro, Takayama, Zentarou, Yamagata, Nobuyuki, Enomoto
Publikováno v:
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 115(8)
The LZ test "Eiken" for H. pylori antibody (LZ test) was examined. In patients with an antibody titer of ≥3.0U/mL and10.0U/mL among 698 patients who underwent breath tests, the status of H. pylori infection was assessed from the results of the
Autor:
Hideki Fujii, Akishi Ooi, Mitsuhiko Hanawa, Hidemitsu Sugai, Kosaku Mimura, Koji Kono, F Mitsui, Naoto Miyagawa
Publikováno v:
British Journal of Cancer
The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach. It is important to clarify the frequencies o
Autor:
Akishi Ooi, Mitsuhiko Hanawa, Yoh Dobashi, Keiichi Nishikawa, Shioto Suzuki, Hiroyuki Sakurai
Publikováno v:
Cancer. 103:1265-1273
BACKGROUND Recently, molecular therapies targeting epidermal growth factor receptor (EGFR) have been developed for clinical use. The current study was conducted to determine 1) the exact frequency of EGFR protein overexpression, 2) the correlation be
Publikováno v:
Modern Pathology. 17:1497-1505
In order to evaluate the involvement of epidermal growth factor receptor, and to analyze the correlation between gene aberration and protein expression in mesenchymal tumors, we examined protein expression by immunohistochemistry in 125 cases of bone
Autor:
Akishi Ooi, Shioto Suzuki, Yoh Dobashi, Satoshi Igarashi, Hirochika Matsubara, Mitsuhiko Hanawa
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 19(7)
The correlations among epidermal growth factor receptor (EGFR) gene amplification, gene mutation, overexpression/phosphorylation of EGFR protein and activation of its downstream molecules, signal transducers and activators of transcription 3 (Stat-3)
Autor:
Koji Kono, Mitsuhiko Hanawa, Shioto Suzuki, Yoh Dobashi, Tetsu Yamane, Nobuyuki Enomoto, Akishi Ooi
Publikováno v:
International journal of cancer. 118(5)
Overexpression of epidermal growth factor receptor (EGFR) is observed in many cancers, sometimes accompanied by gene amplification. Recently, several clinical therapies targeting EGFR were developed, but the eligibility criteria for these therapies i
Autor:
Kousaku Mimura, Mitsuhiko Hanawa, Atsuhito Nakao, Koji Kono, Hideki Fujii, Mirei Kanzaki, Akishi Ooi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 11(13)
Purpose: In the present study, we investigated the degree of protein expression and gene amplification of HER-2 in esophageal squamous cell carcinoma (SCC) cell lines and freshly isolated tumors, and trastuzumab-mediated biological activity, in parti
Autor:
Shioto Suzuki, Yoh Dobashi, Hiroyuki Sakurai, Keiichi Nishikawa, Mitsuhiko Hanawa, Akishi Ooi
Publikováno v:
Cancer (0008543X); Mar2005, Vol. 103 Issue 6, p1265-1273, 9p